FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

AMINOHIPPURATE SODIUM “PAH” (aminohippurate sodium)
Status: Discontinuation
»Therapeutic Categories: Renal

Merck Sharp & Dohme Corp. (New 01/31/2017)

Company Contact Information:

Presentation Posting Date Related Information
20 percent sterile solution for intravenous injection; 10 mL vials (NDC 0006-3395-11) 01/31/2017 This decision is business-related and not based on any safety or efficacy findings with this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English